Sangtian Liu

发表

Predictive and prognostic significance of M descriptors of the 8th TNM classification for advanced NSCLC patients treated with immune checkpoint inhibitors

T. Jiang, S. Ren, Caicun Zhou, 2020, Translational lung cancer research.

Patients With Short PFS to EGFR-TKIs Predicted Better Response to Subsequent Anti-PD-1/PD-L1 Based Immunotherapy in EGFR Common Mutation NSCLC

Jue Fan, S. Ren, Caicun Zhou, 2021, Frontiers in Oncology.

Concurrent use of metformin enhances the efficacy of EGFR-TKIs in patients with advanced EGFR-mutant non-small cell lung cancer—an option for overcoming EGFR-TKI resistance

Xiaozhen Liu, Donglai Chen, Caicun Zhou, 2021, Translational lung cancer research.

Impact of serum vascular endothelial growth factor and interleukin-6 on treatment response to epidermal growth factor receptor tyrosine kinase inhibitors in patients with non-small-cell lung cancer.

Xiaozhen Liu, T. Jiang, Caicun Zhou, 2018, Lung cancer.

EGFR-TKIs plus chemotherapy demonstrated superior efficacy than EGFR-TKIs alone as first-line setting in advanced NSCLC patients with EGFR mutation and BIM deletion polymorphism.

F. Hirsch, Jing Zhao, T. Jiang, 2018, Lung cancer.

Impact of EGFR-TKIs combined with PD-L1 antibody on the lung tissue of EGFR-driven tumor-bearing mice.

T. Jiang, S. Ren, Caicun Zhou, 2019, Lung cancer.

EGFR‐targeted therapy alters the tumor microenvironment in EGFR‐driven lung tumors: Implications for combination therapies

Xiaozhen Liu, T. Jiang, S. Ren, 2019, International journal of cancer.

The combination of anti-KIR monoclonal antibodies with anti-PD-1/PD-L1 monoclonal antibodies could be a critical breakthrough in overcoming tumor immune escape in NSCLC

P. Bunn, D. Chan, Caicun Zhou, 2018, Drug design, development and therapy.

Vertebroplasty by Use of a Strontium-Containing Bioactive Bone Cement

J. Leong, K. Cheung, K. Luk, 2005, Spine.